An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Stereotaxis to Participate in Piper Sandler 35th Annual Healthcare Conference
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Stereotaxis (NYSE: STXS) to participate in the Piper Sandler 35th Annual Healthcare Conference. David Fischel, Chairman and CEO, will present on Stereotaxis’ business and technology during a Fireside Discussion on November 30, 2023, at 1:30 pm ET. He will also be available for one-on-one meetings. The company aims to share its differentiated technology, clinical value, and growth strategy with investors.
Positive
None.
Negative
None.
ST. LOUIS, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that David Fischel, Chairman and CEO, will participate in the Piper Sandler 35th Annual Healthcare Conference.
Mr. Fischel will present on Stereotaxis’ business and technology during a Fireside Discussion on Thursday, November 30, 2023, at 1:30 pm ET. Mr. Fischel will be available for one-on-one meetings that same day.
“We appreciate the opportunity to again participate at the Piper Sandler conference. We look forward to sharing Stereotaxis’ differentiated technology, clinical value, and growth strategy with investors,” says Mr. Fischel.
About Stereotaxis Stereotaxis (NYSE: STXS) is a pioneer and global leader in innovative surgical robotics for minimally invasive endovascular intervention. Its mission is the discovery, development and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide unsurpassed patient care with robotic precision and safety, expand access to minimally invasive therapy, and enhance the productivity, connectivity, and intelligence in the operating room. Stereotaxis technology has been used to treat over 100,000 patients across the United States, Europe, Asia, and elsewhere. For more information, please visit www.stereotaxis.com.
Stereotaxis Contacts: David L. Fischel Chairman and Chief Executive Officer
Kimberly Peery Chief Financial Officer
314-678-6100 investors@stereotaxis.com
FAQ
What conference is Stereotaxis participating in?
Stereotaxis is participating in the Piper Sandler 35th Annual Healthcare Conference.
Who will be presenting on Stereotaxis’ business and technology?
David Fischel, Chairman and CEO, will be presenting on Stereotaxis’ business and technology.
When will the presentation take place?
The presentation will take place on November 30, 2023, at 1:30 pm ET.
What does Stereotaxis aim to share with investors?
Stereotaxis aims to share its differentiated technology, clinical value, and growth strategy with investors.
stereotaxis is the global leader in innovative robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. its mission is the discovery, development and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. these innovations help physicians provide unsurpassed patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. over 100 issued patents support the stereotaxis platform. the core components of stereotaxis’ systems have received regulatory clearance in the united states, european union, japan, canada, china, and elsewhere. for more information, please visit www.stereotaxis.com.